Back
Aardvark Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
AARD
Aardvark Therapeutics, Inc.
Last Price:
$13.25
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and AARD is experiencing slight buying pressure.
Aardvark Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.73 | Sell |
| 20-day SMA: | 13.32 | Sell |
| 50-day SMA: | 11.68 | Buy |
| 200-day SMA: | 11.21 | Buy |
| 8-day EMA: | 13.67 | Sell |
| 20-day EMA: | 13.19 | Buy |
| 50-day EMA: | 12.39 | Buy |
| 200-day EMA: | 10.36 | Buy |
Aardvark Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 51.88 | Buy |
| Chaikin Money Flow: | 18529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.55 - 14.59) | Buy |
| Bollinger Bands (100): | (9.27 - 13.93) | Buy |
Aardvark Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aardvark Therapeutics, Inc. Stock
Is Aardvark Therapeutics, Inc. Stock a Buy?
-
Aardvark Therapeutics, Inc. share price is 13.23 while AARD 8-day simple moving average is 13.73, which is a Sell signal.
-
The stock price of AARD is 13.23 while Aardvark Therapeutics, Inc. 20-day SMA is 13.32, which makes it a Sell.
-
Aardvark Therapeutics, Inc. 50-day simple moving average is 11.68 while AARD share price is 13.23, making it a Buy technically.
-
AARD stock price is 13.23 and Aardvark Therapeutics, Inc. 200-day simple moving average is 11.21, creating a Buy signal.
AARD Technical Analysis vs Fundamental Analysis
Sell
37
Aardvark Therapeutics, Inc. (AARD)
is a Sell
Is Aardvark Therapeutics, Inc. a Buy or a Sell?
-
Aardvark Therapeutics, Inc. stock is rated a SellThe current Aardvark Therapeutics, Inc. [AARD] share price is $13.23. The Score for AARD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Aardvark Therapeutics, Inc. Stock Info
Market Cap:
288M
Price in USD:
13.23
Share Volume:
126K
Aardvark Therapeutics, Inc. 52-Week Range
52-Week High:
19.58
52-Week Low:
4.88
Sell
37
Aardvark Therapeutics, Inc. (AARD)
is a Sell
Aardvark Therapeutics, Inc. Share Price Forecast
-
What is the Aardvark Therapeutics, Inc. stock price today?The Aardvark Therapeutics, Inc. stock price is 13.23 USD today.
-
Will AARD stock go up or go down?Aardvark Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Aardvark Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aardvark Therapeutics, Inc. is overvalued.
Is Aardvark Therapeutics, Inc. Stock a Buy?
-
Aardvark Therapeutics, Inc. share price is 13.23 while AARD 8-day exponential moving average is 13.67, which is a Sell signal.
-
The stock price of AARD is 13.23 while Aardvark Therapeutics, Inc. 20-day EMA is 13.19, which makes it a Buy.
-
Aardvark Therapeutics, Inc. 50-day exponential moving average is 12.39 while AARD share price is 13.23, making it a Buy technically.
-
AARD stock price is 13.23 and Aardvark Therapeutics, Inc. 200-day simple moving average is 10.36, creating a Buy signal.
Fundamental Analysis of Aardvark Therapeutics, Inc.
Is Aardvark Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and a decrease next year of $0.38 per share.
Technical Analysis of Aardvark Therapeutics, Inc.
Should I short Aardvark Therapeutics, Inc. stock?
-
AARD Moving Average Covergence Divergence (MACD) indicator is 0.64, suggesting Aardvark Therapeutics, Inc. is a Buy
-
Aardvark Therapeutics, Inc. Relative Strength Index (RSI) is 51.88, which suggest Aardvark Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Aardvark Therapeutics, Inc. is (10.55 - 14.59), which suggest Aardvark Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Aardvark Therapeutics, Inc. is (9.27 - 13.93), which suggest Aardvark Therapeutics, Inc. is a Buy
* Aardvark Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.